CRON
Cronos GroupCRON
CRON
About: Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Employees: 459
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
104% more call options, than puts
Call options by funds: $8.36M | Put options by funds: $4.1M
57% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 23
4% more funds holding
Funds holding: 176 [Q3] → 183 (+7) [Q4]
0.47% more ownership
Funds ownership: 10.88% [Q3] → 11.35% (+0.47%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
4% less capital invested
Capital invested by funds: $91.3M [Q3] → $87.6M (-$3.74M) [Q4]
9% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 43
Research analyst outlook
We haven’t received any recent analyst ratings for CRON.
Financial journalist opinion
Based on 4 articles about CRON published over the past 30 days
Neutral
GlobeNewsWire
2 days ago
Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET.
Positive
MarijuanaStocks
2 weeks ago
3 Canadian Marijuana Stocks That Could See Big Future Gains
When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appetizing. It is more due to the consistent falls in the sector no real upward push. Even as the cannabis industry as a whole is thriving and showing great long-term success.
Neutral
MarijuanaStocks
2 weeks ago
2 Canadian Marijuana Stocks For Your Upcoming Watchlist
Marijuana stocks are torn between two ferns, and this has created a volatile frenzy in the sector. It could be that people feel the cannabis sector will eventually take the behavior of other sectors when in a less volatile space. Uncertainty brings lots of fears doubts, and caution on how to proceed in the future. Now with tariffs in place with China, packaging and other logistics concerns for businesses could lead to deeper issues and problems.
Positive
MarijuanaStocks
3 weeks ago
3 Canadian Marijuana Stocks For Long-Term Investing
Marijuana stock investors are torn between several paths. With how volatile the space is, much of the sector is trading at low price points. It is almost safe to say that more than half of those who have shares in a cannabis company are down. But that doesn't mean that it will stay that way forever. The overall cannabis industry continues to flourish even though that same success doesn't impact the public sector as it used to.
Positive
MarijuanaStocks
1 month ago
Top Canadian Cannabis Stocks to Watch in April 2025
Top Canadian cannabis stocks are attracting attention this week as investors seek opportunities in a rapidly evolving industry. Companies like Cronos Group, SNDL Inc., and Aurora Cannabis continue strengthening their positions in Canadian and international markets. Though based in Canada, these firms have exposure to the U.S. through strategic investments and partnerships. The U.S. cannabis industry is expected to generate over $45 billion annually by 2025. Legalization efforts are expanding, and several states are reviewing new adult-use and medical cannabis bills. At the same time, court rulings and state-level decisions continue to shape the legal landscape. Because of this, Canadian companies with U.S. exposure are drawing increased interest from traders and long-term investors alike.
Positive
Finbold
1 month ago
Cronos (CRO) soars 31% since Trump teamed up with Crypto.com
The week that started on Monday, March 24, has been bloody in the equity markets and, by Friday, March 28, ensured that cryptocurrencies have also joined the plunge with a $100 billion 24-hour valuation drop.
Positive
Seeking Alpha
1 month ago
Cronos Stock: Win Big Or Lose All
I maintain a 'strong buy' rating for Cronos, despite regulatory headwinds, due to its strong fundamentals and potential for multibagger returns. Cronos has shown positive progress with a robust cash buffer, 35% revenue growth, reduced EBITDA losses, and positive operating cash flows in FY 2024. International expansion, strategic investments, and a focus on R&D are key drivers for Cronos' sustained top-line growth and market diversification.
Neutral
MarijuanaStocks
1 month ago
3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U.S., can greatly affect how shareholders think. Additionally, oversupply in certain regions has led to falling prices, which negatively affects revenue for companies in the sector. This has created a volatile sector where the trading behavior of the most public companies is more on the low end.
Neutral
GlobeNewsWire
1 month ago
Cronos Appoints Anna Shlimak as Chief Financial Officer
TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos' Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition.
Neutral
Seeking Alpha
1 month ago
Cronos Group Inc. (CRON) 37th Annual Roth Conference (Transcript)
Cronos Group Inc. (NASDAQ:CRON ) 37th Annual Roth Conference March 17, 2025 4:00 PM ET Company Participants Mike Gorenstein - Chairman, President and Chief Executive Officer Conference Call Participants Bill Kirk - Roth Capital Partners Bill Kirk Awesome. Good afternoon everybody.
Charts implemented using Lightweight Charts™